» Authors » Michiel Simons

Michiel Simons

Explore the profile of Michiel Simons including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 353
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Korman S, Vissers G, Gorris M, Verrijp K, Verdurmen W, Simons M, et al.
Hum Reprod . 2024 Dec; 40(3):450-460. PMID: 39724530
Study Question: How can we best achieve tissue segmentation and cell counting of multichannel-stained endometriosis sections to understand tissue composition? Summary Answer: A combination of a machine learning-based tissue analysis...
2.
Zelisse H, van Gent M, Mom C, de Ridder S, Snijders M, Heeling M, et al.
Ann Diagn Pathol . 2024 Nov; 74:152411. PMID: 39591762
Fundamental and translational research in ovarian cancer aims to enhance understanding of disease mechanisms and improve treatment and survival outcomes. To support this, we established the Dutch multicenter, interdisciplinary Archipelago...
3.
Mangwani J, Houchen-Wolloff L, Malhotra K, Booth S, Smith A, Teece L, et al.
Bone Joint J . 2024 Oct; 106-B(11):1249-1256. PMID: 39481430
Aims: Venous thromboembolism (VTE) is a potential complication of foot and ankle surgery. There is a lack of agreement on contributing risk factors and chemical prophylaxis requirements. The primary outcome...
4.
Bogaerts J, Steenbeek M, Bokhorst J, van Bommel M, Abete L, Addante F, et al.
J Pathol Clin Res . 2024 Oct; 10(6):e70006. PMID: 39439213
In recent years, it has become clear that artificial intelligence (AI) models can achieve high accuracy in specific pathology-related tasks. An example is our deep-learning model, designed to automatically detect...
5.
Negri S, Fisch C, de Hullu J, van Bommel M, Simons M, Bogaerts J, et al.
BJOG . 2024 Jul; 131(13):1851-1861. PMID: 39054407
Objective: A Serous Tubal Intraepithelial Carcinoma (STIC) without concomitant invasive carcinoma is occasionally identified and associated with a high risk of subsequent peritoneal carcinomatosis. Management needs optimisation. This study explores...
6.
Elze L, van der Post R, Vos J, Mensenkamp A, Pamidimarri Naga S, Hampstead J, et al.
J Natl Cancer Inst . 2024 Jul; 116(12):1904-1913. PMID: 38960732
Background: Individuals with germline pathogenic variants in BRCA1 or BRCA2 are at a high risk of breast and ovarian carcinomas with BRCA1/2 deficiency and homologous recombination deficiency that can be...
7.
Vermorgen S, Gelton T, Bult P, Kusters-Vandevelde H, Hausnerova J, Van de Vijver K, et al.
Mod Pathol . 2023 Dec; 37(2):100417. PMID: 38154654
Endometrial biopsies are important in the diagnostic workup of women who present with abnormal uterine bleeding or hereditary risk of endometrial cancer. In general, approximately 10% of all endometrial biopsies...
8.
Laarhuis B, Janssen M, Simons M, van Kalmthout L, van der Doelen M, Peters S, et al.
Clin Genitourin Cancer . 2023 May; 21(5):e352-e361. PMID: 37164814
Introduction: Prostate specific membrane antigen (PSMA) directed radioligand therapy (RLT) is a novel therapy for metastatic castration-resistant prostate cancer (mCRPC) patients. However, it is still poorly understood why approximately 40%...
9.
Derks Y, Schilham M, Rijpkema M, Smeets E, Amatdjais-Groenen H, Kip A, et al.
Eur J Nucl Med Mol Imaging . 2023 Apr; 50(9):2872-2884. PMID: 37060367
Purpose: Incomplete resection of prostate cancer (PCa) results in increased risk of disease recurrence. Combined fluorescence-guided surgery with tumor-targeted photodynamic therapy (tPDT) may help to achieve complete tumor eradication. We...
10.
Steenbeek M, Van Bommel M, IntHout J, Peterson C, Simons M, Roes K, et al.
Int J Gynecol Cancer . 2023 Apr; 33(6):982-987. PMID: 37045546
Background: Risk-reducing salpingectomy with delayed oophorectomy has gained interest for individuals at high risk for tubo-ovarian cancer as there is compelling evidence that especially high-grade serous carcinoma originates in the...